Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Balsalazide disodium (Giazo) in mild-to-moderate ulcerative colitis
NCT00269438Phase 3Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Dec 2005
- Primary completion
- Mar 2007
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in ulcerative colitis (UC) comparing Balsalazide Arm with Placebo Arm (2 arms). Primary endpoint: Clinical Improvement and Rectal Bleeding Improvement at 8 weeks. Started Dec 2005; status: completed.
02
Drugs
balsalazide
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00269438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00269438.